Category: Finance
Long Shortz with Greenvale Energy: All aboard Alpha Torbanite with a staged approach
Stockhead’s Ashtyn Hiron sits down with Greenvale Energy (ASX:GRV) CEO Mark Turner to hear all about the company’s latest news. Greenvale Energy have adopted a [more…]
Dr Boreham’s Crucible: Vitura Health is the tall poppy in a paddock of weed
Vitura is a pot stock in the rare position of producing revenues, profits … and dividends Vitura’s recent performance (and share price) has been weighed [more…]
Venture Minerals launches enormous 300-hole Stage 2 drill program at its emerging Jupiter REE prospect
Venture Minerals has kicked off a 300-hole drill program at its Jupiter REE prospect in WA’s Mid West Stage 2 focus follows consistent high-grade REE [more…]
What a catch! Thrive Tribe appoints ex-cricketer Shane Lee to its executive team
Former Aussie cricketer Shane Lee joins Thrive as international business development executive and talent manager Lee is now a seasoned sports media personality with [more…]
Long Shortz with Litchfield Minerals: A new copper contender enters the arena with a side of yellowcake
Stockhead’s Sarah Hughan sits down with Litchfield Minerals (ASX:LMS) non-executive chairman Peter Eaglen to hear all about the latest entrant to the ASX. Litchfield Minerals has [more…]
Big win for Silver Mines as development consent for large Bowdens deposit remains unchanged
Silver Mines welcomes a judgement to dismiss the application for a judicial review of the Independent Planning Commission’s development consent for Bowdens silver project NSW’s [more…]
Top 10 at 10: Who’s up 120% on a NVIDIA deal?
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Market Highlights: A night of stagflation in the US as iron ore continues descent
ASX SPI Futures pointing lower after US PPI comes in hot More tech losses on Wall street overnight; Tesla cops another downgrade Oil prices keep [more…]
‘Tide is turning for the healthcare sector’ – ASX biotechs making strong gains in 2024 Part 2
Morgans says more money could flow into ASX healthcare sector in 2024 as higher interest rate cycle stabilises Nyrada soars after lead drug candidate demonstrates [more…]
Lithium Universe wants capitalise on North America’s supply chain gaps: Here’s how
The North American lithium market is in need of local production and refinement capability Global demand is forecast to triple by 2030 Junior stock Lithium [more…]
